2012
DOI: 10.1097/mcg.0b013e318237126c
|View full text |Cite
|
Sign up to set email alerts
|

Non-Hodgkin's Lymphoma Involving the Ileocecal Region

Abstract: Radical resection before chemotherapy should be considered in early-stage ileocecal NHL to achieve a better survival. Palliative resection of the primary lesion before chemotherapy may be necessary in T-cell advanced cases to avoid surgical emergencies during chemotherapy. Owing to the small sample number in this study, a prospective analysis with larger sample number is highly necessary.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
7
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 18 publications
1
7
0
Order By: Relevance
“…And lastly, NSAIDs, Eosinophilic enteritis and malignancies have been described in literature as cause of ulcerations in ileo-cecal region[3,14,19]. These causes were also noted in our study.…”
Section: Discussionsupporting
confidence: 82%
“…And lastly, NSAIDs, Eosinophilic enteritis and malignancies have been described in literature as cause of ulcerations in ileo-cecal region[3,14,19]. These causes were also noted in our study.…”
Section: Discussionsupporting
confidence: 82%
“…Primary gastrointestinal NHL is rare, accounting for only 1% to 4% of malignancies originating from the stomach, small intestine, or colon. 7 11 B-cell lymphoma is the third most common colorectal malignancy after colorectal cancer and neuroendocrine tumors, with an incidence of <0.5%. 5 7 DLBCL is the most common histological subtype of gastrointestinal lymphoma, and is more aggressive than other B-cell lymphomas.…”
Section: Discussionmentioning
confidence: 99%
“…There have been reports of delayed CRS that occurred weeks after CAR T-cell infusion [ 13 - 15 ]. The late manifestation of CRS seemed to be related with late in vivo CAR T-cell expansion [ 11 ]. GI complications in lymphoma patients after CAR T-cell therapy were rare in clinical trials.…”
Section: Discussionmentioning
confidence: 99%